Clinical Trial Update: Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes [NA]

View source ↗

Summary

The clinical trial evaluating grafting of Epidermolysis Bullosa wounds with cultured revertant autologous keratinocytes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Snippet

Sponsor: Stanford University | Conditions: Epidermolysis Bullosa | NA | Status: WITHDRAWN